Poly Medicure Ltd

Common Name
Poly Medicure
Country
India
Sector
Healthcare
Industry
Medical Instruments & Supplies
Employees
3,082
Ticker
POLYMED
Exchange
NATIONAL STOCK EXCHANGE OF INDIA
Description
Poly Medicure Ltd. is a leading manufacturer and exporter in the healthcare and medical equipment sector. Primarily focused on medical devices, its portfolio includes a wide range of products such as ...

Poly Medicure's GHG Emissions Data Preview

In 2025, Poly Medicure completed a corporate carbon footprint assessment and publicly disclosed its greenhouse gas (GHG) emissions according to the GHG Protocol, covering Scope 1 (direct emissions from owned or controlled sources) and Scope 2 (indirect emissions from purchased energy).

However, Poly Medicure has not published a category-level breakdown of its Scope 3 emissions, limiting visibility into specific value chain sources.

Metric (tCO2e)2025202420232022 - 2017
Total Scope 1
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 2
Unspecified Calculation Method
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
0000000
Total Scope 3
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Scope 1 Revenue Intensity (tCO2e/$M)
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
a
Copy restricted. Please purchase to unlock this data.
b
0000000
Download Data

Verified Sources Behind Poly Medicure’s Greenhouse Gas (GHG) Emissions Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Poly Medicure’s data sources below and access millions more through our Disclosure Search.

a. Poly Medicure's Sustainability Report 2025
a. Poly Medicure's Sustainability Report 2025
b. Poly Medicure's Sustainability Report 2024
b. Poly Medicure's Sustainability Report 2024

Insights into Poly Medicure's Operational Emissions

In 2025, the total operational greenhouse gas (GHG) emissions of Poly Medicure amounted to 43,426.68 metric tons of CO2 equivalent. This figure includes both direct emissions from owned or controlled sources (Scope 1) and indirect emissions from purchased energy (Scope 2). a

Compared to 2024, the total operational greenhouse gas (GHG) emissions of Poly Medicure increased by 19.69%, suggesting that the company faced challenges in reducing its emissions from its core operations. a

Poly Medicure's Scope 1 Emissions Over Time

202220232024202508501.7 k2.55 k3.4 ktCO2e+38%-25%+44%
  • Total Scope 1
  • Year-over-Year Change

What are Poly Medicure's Scope 1 emissions?

In 2025, the total Scope 1 emissions of Poly Medicure were 3,337.95 metric tons of CO₂ equivalent (tCO₂e). a

Has Poly Medicure reduced its Scope 1 emissions over time?

Since 2022, Poly Medicure's Scope 1 emissions have increased by 48.35%, reflecting a rising long-term trend in Scope 1 emissions over time. a b

Compared to the previous year (2024), Poly Medicure's Scope 1 emissions increased by 43.89%, suggesting that the company faced challenges in reducing emissions from its directly owned or controlled operations. a

What are Poly Medicure's Scope 2 emissions?

In 2025, Poly Medicure reported Scope 2 greenhouse gas (GHG) emissions of 40,088.73 tCO₂e without specifying the calculation method. a

Has Poly Medicure reduced its Scope 2 emissions over time?

Since 2022, Poly Medicure's Scope 2 greenhouse gas (GHG) emissions ( Unspecified Calculation Method) have increased by 60.61%, reflecting a rising long-term trend in Scope 2 emissions over time. a b

Compared to the previous year (2024), Poly Medicure's Scope 2 emissions (Unspecified Calculation Method) rose by 18.04% in 2025, suggesting that the company faced challenges in reducing emissions from purchased electricity and energy a

What methodology does Poly Medicure use for Scope 2 reporting?

In 2025, Poly Medicure reported its Scope 2 emissions using an unspecified methodology. a

Poly Medicure's Scope 2 Emissions Over Time

2022202320242025015 k30 k45 k60 ktCO2e
  • Total Scope 2 (Unspecified Calculation Method)

Insights into Poly Medicure’s GHG Emissions Intensity Compared to Industry Peers

In 2025, Poly Medicure reported Scope 1 greenhouse gas (GHG) emissions of 3,337.95 tCO₂e and total revenues of USD 195 millions. This translates into an emissions intensity of 17.08 tCO₂e per millions USD. a

Poly Medicure's Scope 1 Emissions Intensity Compared to Peers

101002,00020,000500,000Scope 1 Emissions (tCO2e)502001,0002,00010,000Revenues (Millions of USD)BCOJBBBlue Jet HealthcareYear: 2025Scope 1: 23,877 tCO2eRevenue: $M 120Scope 1 Intensity: 198.82 tCO2e/$MCCConcord BiotechYear: 2025Scope 1: 13 tCO2eRevenue: $M 138Scope 1 Intensity: 0.09 tCO2e/$MAbbott IndiaYear: 2025Scope 1: 232 tCO2eRevenue: $M 750Scope 1 Intensity: 0.31 tCO2e/$MMax Healthcare InstituteYear: 2025Scope 1: 7,264 tCO2eRevenue: $M 809Scope 1 Intensity: 8.98 tCO2e/$MBioconYear: 2025Scope 1: 27,951 tCO2eRevenue: $M 1,762Scope 1 Intensity: 15.87 tCO2e/$MCiplaYear: 2025Scope 1: 38,283 tCO2eRevenue: $M 3,177Scope 1 Intensity: 12.05 tCO2e/$MSyngene InternationalYear: 2024Scope 1: 6,653 tCO2eRevenue: $M 404Scope 1 Intensity: 16.47 tCO2e/$MJB PharmaYear: 2025Scope 1: 5,652 tCO2eRevenue: $M 452Scope 1 Intensity: 12.50 tCO2e/$MNatco PharmaYear: 2025Scope 1: 28,495 tCO2eRevenue: $M 518Scope 1 Intensity: 54.96 tCO2e/$MGlenmark PharmaceuticalsYear: 2025Scope 1: 34,547 tCO2eRevenue: $M 1,539Scope 1 Intensity: 22.45 tCO2e/$MTorrent PharmaceuticalsYear: 2025Scope 1: 8,937 tCO2eRevenue: $M 1,325Scope 1 Intensity: 6.75 tCO2e/$MStrides Pharma ScienceYear: 2023Scope 1: 6,168 tCO2eRevenue: $M 439Scope 1 Intensity: 14.04 tCO2e/$MCohance LifesciencesYear: 2025Scope 1: 31,818 tCO2eRevenue: $M 140Scope 1 Intensity: 227.00 tCO2e/$MOOOrchid PharmaYear: 2025Scope 1: 74,800 tCO2eRevenue: $M 108Scope 1 Intensity: 693.22 tCO2e/$MAlkem LaboratoriesYear: 2025Scope 1: 33,018 tCO2eRevenue: $M 1,499Scope 1 Intensity: 22.03 tCO2e/$MGland PharmaYear: 2025Scope 1: 13,920 tCO2eRevenue: $M 654Scope 1 Intensity: 21.30 tCO2e/$MLupinYear: 2025Scope 1: 82,174 tCO2eRevenue: $M 2,597Scope 1 Intensity: 31.64 tCO2e/$MFortis HealthcareYear: 2025Scope 1: 4,600 tCO2eRevenue: $M 904Scope 1 Intensity: 5.09 tCO2e/$MSun Pharmaceutical IndustriesYear: 2025Scope 1: 156,242 tCO2eRevenue: $M 6,091Scope 1 Intensity: 25.65 tCO2e/$MApollo Hospitals EnterpriseYear: 2023Scope 1: 8,033 tCO2eRevenue: $M 2,003Scope 1 Intensity: 4.01 tCO2e/$MPiramal PharmaYear: 2025Scope 1: 61,351 tCO2eRevenue: $M 1,061Scope 1 Intensity: 57.85 tCO2e/$MIPCA LaboratoriesYear: 2025Scope 1: 169,992 tCO2eRevenue: $M 1,036Scope 1 Intensity: 164.03 tCO2e/$MJJJubilant PharmovaYear: 2025Scope 1: 10,084 tCO2eRevenue: $M 842Scope 1 Intensity: 11.98 tCO2e/$MNarayana HrudayalayaYear: 2025Scope 1: 17,923 tCO2eRevenue: $M 642Scope 1 Intensity: 27.93 tCO2e/$MPoly MedicureYear: 2025Scope 1: 3,338 tCO2eRevenue: $M 195Scope 1 Intensity: 17.08 tCO2e/$M

How does Poly Medicure's GHG emissions intensity compare to its peers?

In 2025, Poly Medicure reported a Scope 1 emissions intensity of 17.08 tCO₂e per millions USD. Compared to the peer group median of 18.88 , this places the company below its industry benchmark, indicating it is more carbon-efficient than most competitors. a

Where does Poly Medicure rank on GHG emissions intensity within its industry?

In 2025, Poly Medicure ranked 13 out of 24 companies in its industry peer group, based on Scope 1 emissions intensity (measured in tCO₂e per millions USD). a

Poly Medicure is therefore positioned in the mid-range of its industry, neither a clear leader nor a laggard in carbon efficiency. a

Want Full Access to Poly Medicure's GHG Emissions Dataset?
Sign Up